Skip to main content
Log in

Echinocystic acid reduces reserpine-induced pain/depression dyad in mice

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Chronic pain has consistently been correlated with depression. Echinocystic acid (EA), a natural triterpone enriched in various herbs and used for medicinal purpose in many Asian countries, exhibits anti-inflammatory and analgesic activities. However, little is known the effects of EA on the depression. In present study, we investigated the anti-depression activities in the mouse model of reserpine-induced pain-depression dyad. Reserpine (1 mg/kg subcutaneously daily for 3 days) caused significant depression-like behaviors and pain sensation. Subsequent treatment of EA (5 mg/kg intragastrically daily for 5 days) attenuated the reserpine-induced pain/depression dyad as shown by the increase of pain threshold and the behaviors in forced swimming test, tail suspension test, and open field test. Furthermore, treatment of EA reversed the decrease of biogenic amines (norepinephrine, dopamine, and serotonin) in the brain region of hippocampus, a structure involved in the formation of emotional disorders. Levels of serotonin receptor 5-HT1A were decreased and levels of 5-HT2A were increased in the reserpine-injected mice. Treatment of EA could restore the alterations of serotonin receptors. At the same time, the increase in GluN2B-containing NMDA receptors, p-GluA1-Ser831, PSD-95 and CaMKII were integrated with the increase in caspase-3 and iNOS levels in the hippocampus of the reserpine-injected mice. EA significantly reversed the changes of above proteins. However, EA did not affect the levels of GluN2A-containing NMDA receptors and the total levels of GluA1 and p-GluA1-Ser845. Our study provides strong evidence that EA attenuates reserpine-induced pain/depression dyad partially through regulating the biogenic amines levels and GluN2B receptors in the hippocampus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Albert PR, Lemonde S (2004) 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist: Rev J Bringing Neurobiol Neurol Psychiatry 10:575–593

    Article  CAS  Google Scholar 

  • Antkiewicz-Michaluk L, Wasik A, Mozdzen E, Romanska I, Michaluk J (2014) Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat. Neurotox Res 26:85–98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arora V, Kuhad A, Tiwari V, Chopra K (2011) Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences. Psychoneuroendocrinology 36:1570–1581

    Article  CAS  PubMed  Google Scholar 

  • Blier P, Abbott FV (2001) Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci 26:37–43

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31–39

    Article  CAS  PubMed  Google Scholar 

  • Bourin M, Mocaer E, Porsolt R (2004) Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 29:126–133

    PubMed  PubMed Central  Google Scholar 

  • Cates LN, Roberts AJ, Huitron-Resendiz S, Hedlund PB (2013) Effects of lurasidone in behavioral models of depression. Role of the 5-HT(7) receptor subtype. Neuropharmacology 70:211–217

    Article  CAS  PubMed  Google Scholar 

  • Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F (2004) The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29:252–265

    PubMed  PubMed Central  Google Scholar 

  • Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63

    Article  CAS  PubMed  Google Scholar 

  • Chen J et al (2015) Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems. Metab Brain Dis 30:129–136

    Article  CAS  PubMed  Google Scholar 

  • De Benedetto GE et al (2014) A rapid and simple method for the determination of 3,4-dihydroxyphenylacetic acid, norepinephrine, dopamine, and serotonin in mouse brain homogenate by HPLC with fluorimetric detection. J Pharm Biomed Anal 98:266–270

    Article  PubMed  Google Scholar 

  • Dellarole A et al (2014) Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling. Brain Behav Immun 41:65–81

    Article  CAS  PubMed  Google Scholar 

  • Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C (2007) Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34:865–877

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dutta A, McKie S, Deakin JF (2015) Ketamine and other potential glutamate antidepressants. Psychiatry Res 225:1–13

    Article  CAS  PubMed  Google Scholar 

  • Elhwuegi AS (2004) Central monoamines and their role in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 28:435–451

    Article  CAS  Google Scholar 

  • Fasick V, Spengler RN, Samankan S, Nader ND, Ignatowski TA (2015) The hippocampus and TNF: common links between chronic pain and depression. Neurosci Biobehav Rev 53:139–159. doi:10.1016/j.neubiorev.2015.03.014

    Article  CAS  PubMed  Google Scholar 

  • Gene RM, Cartana C, Adzet T, Marin E, Parella T, Canigueral S (1996) Anti-inflammatory and analgesic activity of Baccharis trimera: identification of its active constituents. Planta Med 62:232–235

    Article  CAS  PubMed  Google Scholar 

  • Guiard BP, El Mansari M, Blier P (2009) Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors. Curr Drug Targets 10:1069–1084

    Article  CAS  PubMed  Google Scholar 

  • Guo YY et al (2012) Acute stress induces down-regulation of large-conductance Ca2+−activated potassium channels in the lateral amygdala. J Physiol 590:875–886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Joh EH, Gu W, Kim DH (2012) Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-kappaB and MAPK pathways. Biochem Pharmacol 84:331–340

    Article  CAS  PubMed  Google Scholar 

  • Joh EH, Jeong JJ, Kim DH (2014) Inhibitory effect of echinocystic acid on 12-O-tetradecanoylphorbol-13-acetate-induced dermatitis in mice. Arch Pharm Res 37:225–231

    Article  CAS  PubMed  Google Scholar 

  • Karolewicz B, Szebeni K, Gilmore T, Maciag D, Stockmeier CA, Ordway GA (2009) Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression. Int J neuropsychopharmacol Off Sci J Collegium Int Neuropsychopharmacol 12:143–153

    CAS  Google Scholar 

  • Khoshnoodi M, Fakhraei N, Dehpour AR (2015) Possible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice. Pharm Biol 53:739–745

    Article  CAS  PubMed  Google Scholar 

  • Lacivita E, Di Pilato P, De Giorgio P, Colabufo NA, Berardi F, Perrone R, Leopoldo M (2012) The therapeutic potential of 5-HT1A receptors: a patent review. Exp Opin Ther Pat 22:887–902

    Article  CAS  Google Scholar 

  • Li K et al (2013) betaCaMKII in lateral habenula mediates core symptoms of depression. Science 341:1016–1020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu SB et al (2014) Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice. Neuromol Med 16:350–359

    Article  CAS  Google Scholar 

  • Molosh AI, Sajdyk TJ, Truitt WA, Zhu W, Oxford GS, Shekhar A (2013) NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons. Neuropsychopharmacol Off Publ Ame Coll Neuropsychopharmacol 38:1352–1364

    Article  CAS  Google Scholar 

  • Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529–540

    Article  CAS  PubMed  Google Scholar 

  • Murata Y, Yanagihara Y, Mori M, Mine K, Enjoji M (2015) Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior. J Affect Disord 180:1–9

    Article  CAS  PubMed  Google Scholar 

  • Niciu MJ, Ionescu DF, Richards EM, Zarate CA Jr (2014) Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm 121:907–924

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14:383–400

    Article  CAS  PubMed  Google Scholar 

  • Smith GR (1992) The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, or pain. Gen Hosp Psychiatry 14:265–272

    Article  CAS  PubMed  Google Scholar 

  • Szewczyk B et al (2010) Decreased expression of Freud-1/CC2D1A, a transcriptional repressor of the 5-HT1A receptor, in the prefrontal cortex of subjects with major depression. Int J neuropsychopharmacol Off Sci J Collegium Int Neuropsychopharmacol 13:1089–1101

    CAS  Google Scholar 

  • Tomaz VS et al (2014) Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice. Neuroscience 268:236–246

    Article  CAS  PubMed  Google Scholar 

  • Vasquez CE, Riener R, Reynolds E, Britton GB (2014) NMDA receptor dysregulation in chronic state: a possible mechanism underlying depression with BDNF downregulation. Neurochem Int 79:88–97

    Article  CAS  PubMed  Google Scholar 

  • Xu Y et al (2013) Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses. Metab Brain Dis 28:571–583

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by National Natural Science Foundation of China, No. 31271144, 31325022, and 2013DFG32650.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming-gao Zhao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Shuo Li and Jing Han contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, S., Han, J., Wang, Ds. et al. Echinocystic acid reduces reserpine-induced pain/depression dyad in mice. Metab Brain Dis 31, 455–463 (2016). https://doi.org/10.1007/s11011-015-9786-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-015-9786-6

Keywords

Navigation